In 2016, IFCAH exceptionally funded projects on Congenital Adrenal Hyperplasia for an amount of 448 000€: following IFCAH’s call for projects, 21 letters of intent have been received. Among them, 18 where eligible and 7 have been pre-selected for being reviewed and auditioned by the Scientific Council the 4th of July 2016.

Pr Michel Polak (president of IFCAH’s scientific committee) announced on September 10th 2016 the selected projects in front of 4000 endocrinologists from 105 countries at ESPE congress (in Paris this year):

• “The aetiology and characteristics of testicular adrenal rest tumours”, Claashen,(Nijmegen) funding: 66 000 €
• “Prospective study of pregnancy outcomes in women treated early by dexamethasone for congenital adrenal hyperplasia.” , Bachelot,(Paris) funding: 50 000 €
• “Sodium wasting, water balance and fludrocortisone needs in Congenital Adrenal Hyperplasia: the NaCAH Study”, Martinerie,(Paris) funding: 72 000 €
• “Optimizing fertility outcomes for women with CAH- an assessment of endometrial function and pregnancy complications “, G.Conway, (London) funding: 000 €
• “Study of CAH adrenocortical cells reprogrammed from urine: a step towards cell therapy”, L .Guasti , (London) funding by AFM-Telethon : 100 000 €
• “Adrenal Crisis Emergency spray”, Ross, (Sheffield) (renew 2015), funding: 60 000 €

Funded projects summaries will soon be available online on our IFCAH website.